There is growing evidence that the amino-terminal globular domain of apolipoprotein B (apoB) is essential for lipoprotein particle formation in the hepatic endoplasmic reticulum. To identify the structural requirements for its function in lipoprotein assembly, cysteine (Cys) pairs required to form the seven disulfide bonds within the amino-terminal 21% of apoB were replaced in groups or individually by serine. Substitution of Cys pairs required for formation of disulfide bonds 1-3 or 4 -7 (numbered from amino to carboxyl terminus) completely blocked the secretion of apoB28 in transfected HepG2 cells. To identify the specific disulfide bonds required for secretion, Cys pairs were mutated individually. Substitution of Cys pairs required for disulfide bonds 1, 3, 5, 6, or 7 had little or no impact on apoB28 secretion or buoyant density. In contrast, individual substitution of Cys pair 2 (amino acid residues 51 and 70) or 4 (218 and 234) severely inhibited apoB28 secretion and its capacity to undergo intracellular assembly with lipid. The same assembly and secretion defects were observed when these mutations were expressed as part of apoB50. These studies provide direct evidence that the ability of the internal lipophilic regions of apoB to engage in the recruitment and sequestration of lipid during translation is critically dependent upon a structural configuration contained within or affected by the amino-terminal 5% of the protein.
There is growing evidence that the amino-terminal globular domain of apolipoprotein B (apoB) is essential for lipoprotein particle formation in the hepatic endoplasmic reticulum. To identify the structural requirements for its function in lipoprotein assembly, cysteine (Cys) pairs required to form the seven disulfide bonds within the amino-terminal 21% of apoB were replaced in groups or individually by serine. Substitution of Cys pairs required for formation of disulfide bonds 1-3 or 4 -7 (numbered from amino to carboxyl terminus) completely blocked the secretion of apoB28 in transfected HepG2 cells. To identify the specific disulfide bonds required for secretion, Cys pairs were mutated individually. Substitution of Cys pairs required for disulfide bonds 1, 3, 5, 6, or 7 had little or no impact on apoB28 secretion or buoyant density. In contrast, individual substitution of Cys pair 2 (amino acid residues 51 and 70) or 4 (218 and 234) severely inhibited apoB28 secretion and its capacity to undergo intracellular assembly with lipid. The same assembly and secretion defects were observed when these mutations were expressed as part of apoB50. These studies provide direct evidence that the ability of the internal lipophilic regions of apoB to engage in the recruitment and sequestration of lipid during translation is critically dependent upon a structural configuration contained within or affected by the amino-terminal 5% of the protein.
Little is known about how the initial folding of apolipoprotein B (apoB) 1 influences its interactions with microsomal triglyceride transfer proteins (MTP) and other factors to initiate the process of hepatic apoB-containing lipoprotein assembly (1) (2) (3) . Although incapable of assembling with appreciable lipid on its own (4 -7), the amino-terminal disulfide-bonded region of apoB may, nonetheless, be essential for lipoprotein assembly. Based on the use of dithiothreitol (DTT) to probe protein folding in vivo, the amino-terminal domain of apoB was shown to undergo a folding reaction that is completed before the translation and translocation of the internal lipophilic regions of apoB. If DTT was added to cells during the translation of this domain, thereby preventing its proper folding, apoB was incapable of engaging in lipoprotein assembly (8, 9) . Although these and other studies (7) are consistent with an essential role in the initiation of lipoprotein assembly, it is not known which, among the seven disulfide bonds present in the amino-terminal 21% of apoB (10) , are required for this function. Furthermore, it could not be established whether the block in lipoprotein assembly caused by DTT was caused only by perturbed apoB aminoterminal folding or whether it also resulted from DTT-mediated inhibition of one or more assembly factors.
In the current study, the relationship between the structure of the amino-terminal domain of apoB and its capacity to initiate lipoprotein assembly in vivo was examined by performing systematic mutagenesis to disrupt its normal pattern of disulfide bonding (10) . Individual substitution of five of the seven Cys pairs within the amino-terminal domain had little or no impact on apoB assembly or secretion. However, substitution of Cys pairs required for formation of disulfide bonds 2 or 4 virtually abolished the capacity of both apoB28 and apoB50 to engage in lipoprotein particle assembly and secretion. These studies indicate that the ability of the lipophilic regions of apoB (11) to engage in lipid recruitment and sequestration during translation is critically dependent upon a structural configuration within or affected by the amino-terminal 5% of the protein.
It is possible that this domain serves as part of a recognition site for MTP or engages in an initial lipid recruitment step required to convert nascent apoB polypeptides into acceptor particles for the cotranslational phase of MTP-dependent lipid transfer.
EXPERIMENTAL PROCEDURES
Materials-Restriction and DNA modification enzymes were from New England Biolabs. Tissue culture media and supplements were obtained from ICN (Irvine, CA) or MediaTech (Washington, D. C.). Tran 35 S-label (ϳ5:1 mixture of [ 35 S]Met and Cys) was from ICN. Anti-FLAG M2 monoclonal antibody (an antibody that recognizes the 8-amino acid FLAG epitope (DYKDDDDK) positioned at the carboxylterminal end of apoB28F and apoB50F) and anti-FLAG M2-agarose were from Eastman Kodak Scientific Imaging Systems (New Haven, CT). FLAG peptide was synthesized and purified by the Protein Analysis Core Laboratory of the Comprehensive Cancer Center of Wake Forest University. Centricon-10 and Centriprep-10 centrifugal concentrators were from Amicon (Beverly, MA).
Mutagenesis of ApoB28F and ApoB50F cDNA-Pairwise Cys to Ser mutations were made in apoB28F (9) to disrupt the seven disulfide linkages reported in human low density lipoprotein apoB (10) (C1-C7; Fig. 1A ). Mutations were introduced by overlap PCR extension (12) using primers containing T to A substitutions in the first position of the appropriate Cys codons (13) . PCR amplification products were digested with restriction enzymes, purified by agarose gel electrophoresis, and used to replace the corresponding restriction fragment of wild type apoB28F cloned into pBluescript II SKϩ (9) . The following restriction * This work was supported by National Institutes of Health Grant HL49373 and was performed during the tenure of an established investigatorship from the American Heart Association (G. S. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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sites with corresponding amino acid coordinates (13) in parentheses were employed for each Cys to Ser mutant: C1 and C2, restrictions sites KasI (Ϫ4) and EcoNI (ϩ74); C3, KasI (Ϫ4) and BclI (ϩ212); C4 and C5, BclI (ϩ212) and BstEII (ϩ385); C6, BstEII (ϩ385) and HindIII (ϩ691); C7 BamHI (ϩ782) and XhoI (ϩ1286). Multiple mutations were obtained by using mutant apoB28F as a template for subsequent PCRs and as the recipient for the mutant PCR restriction fragments. Once the appropriate sequence alterations were completed in the pBluescript plasmid, the entire apoB28 coding region was transferred to the pCMV5 expression vector (14) . This was accomplished by digesting wild type apoB28F contained in pCMV5 with EcoRI (5Ј-flanking site) and XhoI (3Ј-end of the apoB28 coding sequence) and replacing it with the same restriction fragment generated by digestion of the mutant apoB28F pBluescript clone. All mutations were verified by sequencing the entire area within each clone that was created by PCR. Mutant forms of apoB50F were made by digesting the appropriate apoB28F mutant plasmid with EcoRV (amino acid 580) and KpnI (3Ј-flanking site) and replacing it with the EcoRV and KpnI fragment from wild type apoB50F (15) .
Tissue Culture and Metabolic Labeling-HepG2 cells were cultured in Eagle's minimal essential medium containing 10% fetal bovine serum (8) . For studies involving apoB secretion 35-mm dishes in six-well format were employed. For studies in which apoB from cells or media was analyzed by density gradient centrifugation or proteolytic digestion, 150-mm dishes were employed. In both cases, cells were transiently transfected by the calcium phosphate method and subjected to metabolic labeling 48 -72 h after transfection, as described (8, 9) .
Immunoprecipitation and Gel Electrophoresis-After metabolic labeling, media and cells were recovered and subjected to immunoprecipitation with anti-FLAG M2 monoclonal antibody and protein GSepharose as described (15) . Immune pellets were boiled in SDS-PAGE sample buffer (50 mM Tris base, 4% SDS, 12% glycerol, 1 mM EDTA, 0.05% bromphenol blue) containing 100 mM DTT for 5 min. After centrifugation, supernatants were analyzed by 8% SDS-PAGE. Gels were soaked in 1 M sodium salicylate, dried, and exposed to x-ray film (16) . Quantitation of radioactive band intensity was performed with a model 445 SI PhosphorImager (Molecular Dynamics) or by film densitometry using a pdi 325oe scanning densitometer (Protein and DNA Imageware Systems).
Proteolytic Digestion-Transiently transfected HepG2 cells (150-mm dishes) were lysed as described (15) with 1 ml of lysis buffer (25 mM Tris HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100) containing 1 mM phenylmethylsulfonyl fluoride, 10 g of leupeptin, 10 g/ml pepstatin. After centrifugation to remove nuclei and cell debris, supernatants were adjusted to 2.5 mg/ml bovine serum albumin and incubated for 3.5 h with gentle inversion at 4°C with anti-FLAG M2 monoclonal antibody conjugated to agarose beads (50-l bed volume). After washing the beads three times with lysis buffer, bound proteins were displaced by two rounds of batch elution with 125 l of lysis buffer containing 100 g/ml bovine serum albumin and 150 g/ml FLAG peptide. The eluted fractions were pooled and incubated with trypsin (0.5 g/ml; Boehringer Mannheim) at room temperature. At the times indicated, 20-l aliquots were removed from the reaction and added to microcentrifuge tubes containing soybean trypsin inhibitor (final concentration of 500 g/ml). Samples were subsequently adjusted to 5 mM phenylmethylsulfonyl fluoride and incubated in ice for 15 min. After addition of an equal volume of 2 ϫ SDS-PAGE sample buffer, samples were boiled for 10 min and subjected to 8% SDS-PAGE.
RESULTS

Effects of Sequential Cys to Ser Substitutions on ApoB28F
Secretion-Seven of the eight disulfide bonds present in apoB100 are positioned within the amino-terminal 21% of the protein (10) . The effects of disrupting these disulfide bonds were assessed using a polypeptide containing the amino-terminal 28% of apoB to which the 8-amino acid FLAG epitope was attached at the carboxyl-terminal end (apoB28F) (9, 17) . Sequential disruption of disulfide bonds from the amino-and carboxyl-terminal ends of apoB28F (Fig. 1A) was achieved by making pairwise Cys to Ser substitutions as described under "Experimental Procedures." Transiently transfected HepG2 cells expressing the wild type and mutant forms of apoB28F were metabolically labeled for 3 h with [
35 S]Met/Cys, and the amount of radioactive protein present in media and cells was assessed by immunoprecipitation followed by SDS-PAGE and fluorography. When the 2 Cys residues required to form disulfide bond 1 (C1) were mutated to Ser, the ratio of apoB28F in media and cells was unaffected relative to wild type (Fig. 1B) . However, when Cys pairs 1 and 2 (C1-2) or 1, 2, and 3 (C1-3) were mutated, apoB28F secretion was essentially abolished. No inhibition of secretion was observed upon substitution of Cys pair 7 (C7). An ϳ50% decrease in the media:cell ratio was observed when Cys pairs 6 and 7 (C6 -7) or 5, 6, and 7 (C5-7) were mutated. Finally, when Cys pairs 4 -7 (C4 -7) were replaced by Ser a complete block in secretion was observed.
Disulfide Bonds 2 and 4 Are Essential for ApoB28F Secretion-The analysis above suggests that Cys pairs 2 and 4 may individually be critical for apoB secretion. To confirm this, individual Cys pair mutations were made in apoB28F, and the effects on secretion were assessed by pulse-chase analyses. Transiently transfected HepG2 cells were pulsed for 10 min with 35 [S]Met/Cys and chased for the times indicated with medium containing an excess of unlabeled amino acids (Fig. 2) . ApoB28F bearing mutations in Cys pairs 1, 3, 5, and 7 (C1, C3, C5, C7) displayed little or no effect on secretion kinetics or efficiency relative to wild type. In each case ϳ40 -55% of the peak apoB28F radioactivity present in cells after the 10-min pulse was recovered in the medium after 3 h of chase. Substitution of Cys pair 6 (C6) caused a partial secretion defect in which only 15% of the apoB28F synthesized during the 10-min pulse was recovered in the medium. As predicted from the sequential deletion analysis (Fig. 1B) , individual pairwise Cys to Ser substitutions that block formation of disulfide bonds 2 or 4 (C1, C2) virtually abolished apoB28F secretion. In both cases less than 3% of the peak apoB28F radioactivity present in cells after the pulse was recovered in the medium after 3 h of chase. Although these mutations inhibited secretion, they did not affect intracellular degradation dramatically. For mutants C2 and C4, ϳ60 -80% of the peak radioactivity present in cells after the pulse was recovered in cells and medium after the 3-h chase, a value similar to that observed for the wild type.
Cys Pairs 2 and 4 Are Essential for ApoB28F Lipid Recruitment in the Endoplasmic Reticulum (ER)-
The requirement for disulfide bonds 2 and 4 in the assembly of apoB was explored further by examining the effects of Cys mutations on the capacity of apoB28 to recruit lipid intracellularly. For these studies the buoyant density of wild type apoB28F from intracellular pools was compared with that of mutant forms that had either no impact on apoB secretion (C1) or inhibited secretion strongly (C2 and C4). Transiently transfected HepG2 cells were labeled for 3 h with [ 35 S]Met/Cys, and postnuclear membranes were prepared and extracted with sodium carbonate, pH 11.5, to obtain lumenal contents (15) . After centrifugation, pellet fractions were subjected directly to immunoprecipitation. Supernatant fractions were neutralized, adjusted to 1.25 g/ml with KBr, and analyzed by equilibrium density gradient centrifugation as described (9) . The top (d Ͻ 1.25 g/ml) and bottom (d Ͼ 1.25 g/ml) fractions were immunoprecipitated and fractionated along with the carbonate-extracted membrane pellets by SDS-PAGE. As shown in Fig. 3 , carbonate-extractable wild type apoB28F and the C1 mutant were recovered in the lipoproteincontaining top fractions, whereas the C2 and C4 forms were predominantly confined to the bottom fractions. These results indicate that apoB28F incapable of forming disulfide bonds 2 or 4 is defective in its ability to recruit or sequester lipid in the ER.
Cys Pairs 2 and 4 Are Essential for the Assembly and Secretion of ApoB50-containing
Lipoproteins-Based on the cotranslational nature of the initial stage of lipoprotein assembly it can be assumed that steps required to initiate small forms of apoB, such as apoB28, are similar to those required to initiate native apoB48 and 100-containing lipoproteins (4, 18) . To confirm this prediction, several of the mutant apoB28F cDNA clones were extended with wild type apoB sequences to form the equivalent carboxyl-terminal epitope-tagged form of apoB50 (apoB50F) (15) . When these constructs were expressed and analyzed as described in Fig. 1B , the same pattern of secretion was observed. Both wild type and the C1 forms of apoB50F were found in media and cells at equivalent ratios ( Fig. 4 ; the arrow indicates apoB50F; an asterisk, a protein that immunoprecipitates nonspecifically). However, individual pairwise substitution of Cys residues required for disulfide bonds 2 and 4 severely inhibited the secretion of apoB50F from transiently transfected HepG2 cells.
Because apoB50F contains more extensive lipid binding sequences than apoB28F (11) we explored the possibility that, although incapable of secretion, mutant forms were able to recruit an appreciable amount of lipid intracellularly. As displayed in Fig. 5 , most of the carbonate-extractable apoB50F wild type and C1 mutant floated in the top, d Ͻ 1.25 g/ml gradient fraction. For the C2 and C4 mutations, a small amount of buoyant apoB50F was observed. However, the ratio of buoyant to lipid poor apoB50F was much lower for disulfide bond mutants C2 and C4 (ϳ0.5) compared with the wild type and C1 mutant (ϳ6). Furthermore, relative to the wild type and C1 mutant, a smaller percentage of the C2 and C4 forms of apoB50F was extracted by sodium carbonate. This behavior would be expected for apoB that was unable to engage in lipoprotein assembly and, therefore, may engage in binding to the inner leaflet of the ER membrane or aggregation. We conclude, therefore, that Cys pairs 2 and 4 are essential for the assembly of native forms of apoB.
Structural Analyses of Cys Pair Mutants-To examine whether Cys to Ser substitutions grossly affected the pattern of disulfide bonding, wild type and mutant forms of apoB from intracellular pools were analyzed by nonreducing SDS-PAGE (9) . In each case, the mobility of each protein was similar and, more critically, existed as a single electrophoretic species (data not shown). This result indicates that removal of one disulfide bond does not disrupt disulfide bonding elsewhere in the molecule and that a predominant structural configuration exists 35 S]Met/Cys for 3 h, a postnuclear membrane fraction was obtained and extracted with sodium carbonate, pH 11.5. After centrifugation the pellet (P) was solubilized and subjected to direct immunoprecipitation. The carbonate supernatant was neutralized, adjusted to 1.25 g/ml with KBr (total volume, 3 ml), and analyzed by equilibrium density gradient centrifugation as described (9) . ApoB28F was recovered from the top 1-ml (T) and bottom 2-ml (B) fractions by immunoprecipitation.
for each mutant. Intracellular forms of wild type and mutant apoB28F were also digested with proteases to assess possible conformational differences caused by mutagenesis (19) . As observed in Fig. 6 , the overall susceptibilities of both wild type and mutant forms of apoB28F to proteolytic degradation are similar. However, the wild type and C1 mutants, both of which are assembly-and secretion-competent, were cleaved internally giving rise to two predominant peptides of ϳ65 and 75 kDa. In contrast, the assembly-defective mutants, C2 and C4, displayed only limited formation of these peptides and instead produced a larger peptide of ϳ120 kDa. These results indicate that disruption of either the C2 or C4 disulfide bond affects the capacity of apoB28 to fold into a conformation capable of engaging in lipoprotein formation in the ER. DISCUSSION Previous studies in which DTT was used to perturb disulfide bonding in apoB28 (9) and apoB100 (8) indicated that the amino-terminal disulfide-bonded domain of apoB may be critically important for the initiation of apoB-containing lipoprotein assembly. However, because of the relatively wide distribution of disulfide bonds within the amino-terminal 950 amino acids of apoB it was not possible to identify which of the seven disulfide bonds are essential. In the current report Cys pairs involved in disulfide bond formation within the amino-terminal 21% of apoB were systematically replaced in groups or individually by Ser, and the effects on apoB-containing lipoprotein assembly and secretion were assessed. Remarkably, it was found that disruption of two of the four Cys pairs located within the amino-terminal 5% of apoB severely limited the ability of apoB28 and apoB50 to engage in lipoprotein particle assembly. Because we have shown previously that the disulfide bonds in the amino-terminal domain of apoB form during the process of translation (8, 9) it can be concluded that folding events that occur almost immediately after entry of apoB into the ER are critically important to promote hepatic lipoprotein assembly.
Digestion of the two assembly-defective forms of apoB (C2 and C4) with trypsin revealed a different pattern of degradation relative to wild type and an assembly-competent mutant (C1) (Fig. 6 ). This result indicates that the C2 and C4 forms of apoB28F exist intracellularly in an altered conformation which prevents lipoprotein formation. However, it is possible that the structural differences observed in the C2 and C4 mutants are not inherent to the altered folding per se but instead reflect the absence of a conformational change that occurs upon assembly with lipid. In this regard, it will be of interest to examine the pattern of protease digestion for both wild type and mutant forms of apoB expressed in lipoprotein-producing and nonlipoprotein-producing cell lines.
Although the data presented here provide compelling evidence as to the importance of the amino-terminal region of apoB in lipoprotein assembly, it is not known how this domain functions. Previous studies have demonstrated a physical interaction between MTP and the amino-terminal domain of apoB (20, 21) . It is possible therefore that discrete disulfidebonded loops within this domain form a critical recognition site for the initial interaction of MTP with the nascent apoB polypeptide chain. In addition, the amino-terminal domain of apoB has been shown to recruit phospholipid autonomously upon incubation in vitro with vesicles composed of dimyristoylphosphatidylcholine (22) or during cell-free translation in the presence of rat liver microsomes (23) . Hence, an alternative or additional function provided by the amino-terminal domain of apoB may involve recruitment of a phospholipid surface that serves as an acceptor site for MTP-dependent transfer of neutral and polar lipids. This recruitment step could be achieved in a number of ways including formation of a membranous bleb or bud on the lumenal side of the ER membrane (4, 24, 25) . The requirement of the amino-terminal domain to initiate or achieve this budding process is supported in part by studies demonstrating that forms of apoB containing as little as the amino-terminal 15% of the protein are capable of inserting into the inner leaflet of the ER membrane in a carbonate-inextractable form (26) .
In large part, the various hypothetical functions of the amino-terminal domain of apoB discussed above are based on cellfree assays. However, no experimental relationship has been established to link the capacity of the amino-terminal domain to interact with MTP, lipids, and membranes in vitro and its 35 S]Met/Cys for 3 h, a postnuclear membrane fraction was obtained and extracted with sodium carbonate, pH 11.5. After centrifugation the pellet (P) was solubilized and subjected to direct immunoprecipitation. The carbonate supernatant was subjected to density gradient centrifugation as described in Fig. 3 . The top 1-ml (T) and bottom 2-ml (B) fractions were subjected to immunoprecipitation. T/B is the ratio of apoB50F in the top and bottom fractions.
FIG. 6.
Assembly-defective forms of apoB28F recovered from cells display an altered structure. HepG2 cells expressing wild type apoB28F and the C1, C2, and C4 mutants were labeled for 2 h with [ 35 S]Met/Cys and subjected to lysis in non-ionic detergent. After affinity purification, aliquots were digested with trypsin for the times indicated and analyzed by SDS-PAGE and fluorography. Arrows on the left indicate two predominant peptides generated by cleavage of assemblycompetent forms of apoB28F (wild type and C1). The arrow on the right indicates the position of a peptide generated by digestion of assemblydefective forms of apoB28F (C2 and C4). Migration of molecular mass standards is indicated in kDa. Non-full-length bands present in the untreated (0 min) lanes are nonspecific polypeptides that copurify with apoB28F during immunoaffinity isolation. ability to initiate lipoprotein particle assembly in vivo. It will be of interest to assess how the same structural alterations produced by mutagenesis which affect lipoprotein assembly in cells will affect the capacity of this domain to associate with MTP, lipids, and membranes in cell-free assays. The critical function of the amino-terminal domain may emerge by identifying which cell-free assay(s) display a structure-function profile similar to that observed for the capacity of apoB to initiate lipoprotein assembly in vivo.
Although disulfide bonds 2 and 4 appear necessary for apoB assembly and secretion it is interesting that removal of five of the seven disulfide bonds within the amino-terminal domain of apoB had little or no impact on secretion (Figs. 1 and 2 ) or buoyant density (data not shown). It is not uncommon that mutagenic removal of disulfide bonds fails to affect and can even enhance folding and secretion rates (27, 28) . However, it is also possible that the insensitivity of apoB assembly to substitution of particular Cys pairs reflects the multifunctional nature of the amino-terminal domain. For example, disulfide bond mutations that fail to affect the first cotranslational phase of lipoprotein assembly, which predominates in HepG2 cells (4), could nonetheless have an impact on the posttranslational ability of apoB48 to form very low density lipoprotein particles in hepatocytes or oleate stimulated rat hepatoma cells (29, 30) . It is also conceivable that although competent for secretion, these disulfide bond mutations will affect intravascular aspects of apoB metabolism such as its ability to undergo lipoprotein lipase-mediated lipolysis (31, 32) or its ability to undergo the conformational changes that are required for it to function as a ligand for the low density lipoprotein receptor (33) .
One of the most common genetic disorders involving apoB (1/500 -1/1000 in Western populations) is heterozygous hypobetalipoproteinemia (34) . In these individuals frameshift and nonsense mutations result in the production of truncated forms of the apoB protein. Invariably, these mutations result in low plasma low density lipoprotein cholesterol either because of reduced expression of the mutant allele or an enhanced rate of intravascular clearance. However, in cases where mutations were predicted to form very short apoB proteins (smaller than apoB30), no evidence of truncated apoB was detected in plasma (35, 36) . Based on the results presented here, it is a formal possibility that missense mutations at one of the 4 Cys residues required for the formation of disulfide bonds 2 or 4 or at other residues that participate in the formation of this critical aminoterminal structural domain could underlie some cases of this lipid disorder.
